Eastman Chemical (EMN) Liabilities and Shareholders Equity (2009 - 2026)

Eastman Chemical has reported Liabilities and Shareholders Equity for 18 years, with the latest figure at $15.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 1.68% year-over-year to $15.2 billion; the trailing twelve-month figure through Mar 2026 stood at $60.3 billion (changed 0.15% YoY), and the FY2025 full-year result was $14.9 billion, down 2.33% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $15.2 billion, up from $14.9 billion in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $15.8 billion in Q1 2022, with the low at $14.6 billion in Q3 2023.
• Historically, Liabilities and Shareholders Equity has averaged $15.0 billion across 5 years, with a median of $15.0 billion in 2025.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity slipped 7.84% — and 2024, when it rose 3.96%.
• Eastman Chemical's Liabilities and Shareholders Equity stood at $14.7 billion in 2022, then retreated by 0.23% to $14.6 billion in 2023, then gained by 3.96% to $15.2 billion in 2024, then fell by 2.33% to $14.9 billion in 2025, then grew by 2.44% to $15.2 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $15.2 billion (Q1 2026), $14.9 billion (Q4 2025), and $15.0 billion (Q3 2025), per Business Quant data.